As with peripheral blood results, there is also an increase in SARS-CoV-2-specific CD8+ T cells in the respiratory tract of moderate COVID-19, as demonstrated in bronchoalveolar lavage fluid collected from COVID-19 patients. This evidence concerns the gene CD8A and COVID-19.